Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridostigmine vs. Fludrocortisone for Autonomic Dysregulation in Parkinson's Disease
NCT01993680Phase 2Completed
- Start
- Jun 2012
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pyridostigmine in Parkinson's disease (PD). Started Jun 2012; status: completed.
02
Drugs
pyridostigmine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01993680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01993680.